Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function

Science

Volumn 289, Issue 5479, 2000, Pages 633-637

  Kaneko, Satoshi ^a   Hikida, Takatoshi ^a   Watanabe, Dai ^a   Ichinose, Hiroshi ^b   Nagatsu, Toshiharu ^b   Kreitman, Robert J ^c   Pastan, Ira ^c   Nakanishi, Shigetada ^a  

^a KYOTO UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; APOMORPHINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; IMMUNOTOXIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; GLOBUS PALLIDUS; IMMUNOREACTIVITY; MOTOR ACTIVITY; MOUSE; NERVE CELL LESION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SYNAPTIC TRANSMISSION;

ACETYLCHOLINE; ANIMALS; APOMORPHINE; BASAL GANGLIA; CHOLINE O-ACETYLTRANSFERASE; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOWN-REGULATION; ENKEPHALINS; IMMUNOTOXINS; INTERNEURONS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; OXIDOPAMINE; POSTURE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, GLUTAMATE; SUBSTANCE P; SYNAPSES;

ANIMALIA;

EID: 0034725783     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.289.5479.633     Document Type: Article

References (41)

1. A. M. Graybiel, T. Aosaki, A. W. Flaherty, M. Kimura, Science 265, 1826 (1994).
2. A. M. Graybiel, Curr. Opin. Neurobiol. 5, 733 (1995).
3. J. C. Houk and S. P. Wise, Cereb. Cortex 5, 95 (1995).
4. W. Schultz, P. Apicella, R. Romo, E. Scarnati, in Models of Information Processing in the Basal Ganglia, J. C. Houk, J. L. Davis, D. G. Beiser, Eds. (MIT Press, Cambridge, MA, 1995), chap. 2.
5. T. W. Robbins and B. J. Everitt, Curr. Opin. Neurobiol. 6, 228 (1996).
6. R. L. Albin, A. B. Young, J. B. Penney, Trends Neurosci. 12, 366 (1989).
7. M. Hallett, Can. J. Neurol. Sci. 20, 177 (1993).
8. M. F. Chesselet and J. M. Delfs, Trends Neurosci. 19, 417 (1996).
9. T. Wichmann and M. R. DeLong, Curr. Opin. Neurobiol. 6, 751 (1996).
10. G. E. Alexander and M. D. Crutcher, Trends Neurosci. 13, 266 (1990).
11. C. J. Wilson, in The Synaptic Organization of the Brain, G. M. Shepherd, Ed. (Oxford Univ. Press, New York, 1998), chap. 9.
12. C. R. Gerfen et al., Science 250, 1429 (1990).
13. G. Di Chiara, M. Morelli, S. Consolo, Trends Neurosci. 17, 228 (1994).
14. H. Steiner and C. R. Gerfen, Exp. Brain Res. 123, 60 (1998).
15. G. S. Robertson, S. R. Vincent, H. C. Fibiger, Neuroscience 49, 285 (1992).
16. V. Bernard, B. Dumartin, E. Lamy, B. Bloch, Eur. J. Neurosci. 5, 1218 (1993).
17. K. Berger, S. Przedborski, J. L. Cadet, Brain Res. Bull. 26, 301 (1991).
18. M. Xu et al., Cell 79, 945 (1994).
19. J. H. Baik et al., Nature 377, 424 (1995).
20. B. Giros, M. Jaber, S. R. Jones, R. M. Wightman, M. G. Caron, Nature 379, 606 (1996).
21. P. E. Phelps, C. R. Houser, J. E. Vaughn, J. Comp. Neurol. 238, 286 (1985).
22. D. Watanabe et al., Cell 95, 17 (1998).
23. H. Ohishi, R. Shigemoto, S. Nakanishi, N. Mizuno, Neuroscience 53, 1009 (1993).
24. Supplemental Web material is available at www. sciencemag.org/feature/data/1051149.shl.
25. K. Kobayashi et al., Proc. Natl Acad. Sci. U.S.A. 92, 1132 (1995).
26. The IG16 and IC17 lines of heterozygous transgenic mice and their wild-type littermates (22) were deeply anesthetized with sodium pentobarbital at the ages of 7 to 13 weeks. A glass needle was introduced into the left hemisphere with stereotaxic techniques (24), and the anti-Tac(Fv)-PE38 immunotoxin (10 ng/0.5 μl of PBS) or PBS alone was slowly injected into five points in the left striatum over 3 min. For 6-OHDA treatment, PBS (0.5 μl) containing 6-OHDA hydrobromide (4 mg/ml) and 0.016% ascorbic acid was injected into two points in the left striatum over 1 min. All procedures were performed according to guidelines of Kyoto University Faculty of Medicine.
27. S. Kaneko, unpublished data.
28. ACh contents in the striatum were measured with radioimmunoassay as described by K. Kawashima, H. Ishikawa, and M. Mochizuki [J. Pharmacol. Methods 3, 115 (1980)]. DA, DOPAC, and HVA contents in the striatum were measured with high-performance liquid chromatography as described by M. Warnhoff [J. Chromatogr. 307, 271 (1984)]. Levels of ACh, DA, DOPAC, and HVA in the intact striatum of wild-type mice were 760 ± 50, 616 ± 24, 29.0 ± 0.9, and 31.7 ± 1.3 pmol/mg of protein (mean ± SEM), respectively. Statistical analysis was performed by analysis of variance, and post hoc comparisons for this analysis and for histological and behavioral analysis were made with Fisher's protected least significant difference and Scheffé test, respectively.
29. ACh contents in the striatum were measured with radioimmunoassay as described by K. Kawashima, H. Ishikawa, and M. Mochizuki [J. Pharmacol. Methods 3, 115 (1980)]. DA, DOPAC, and HVA contents in the striatum were measured with high-performance liquid chromatography as described by M. Warnhoff [J. Chromatogr. 307, 271 (1984)]. Levels of ACh, DA, DOPAC, and HVA in the intact striatum of wild-type mice were 760 ± 50, 616 ± 24, 29.0 ± 0.9, and 31.7 ± 1.3 pmol/mg of protein (mean ± SEM), respectively. Statistical analysis was performed by analysis of variance, and post hoc comparisons for this analysis and for histological and behavioral analysis were made with Fisher's protected least significant difference and Scheffé test, respectively.
30. Mice were placed in a round-bottom glass bowl (25 cm in diameter), and rotations were counted for a 5-min period by visual observation. One rotation was defined by the animal completing a 360° circle without turning back to the opposite direction. Apomorphine-HCl (1 mg/kg) and haloperidol (6 mg/kg) were injected 15 min before measuring rotations.
31. C. J. Pycock, Neuroscience 5, 461 (1980).
32. 35S]-riboprobe and digoxigenin-labeling hybridization was performed according to procedures described previously (23) and those described by Le Moine and Bloch (37), respectively.
33. A. I. Levey et al., Proc. Natl. Acad. Sci. U.S.A. 90, 8861 (1993).
34. 3H]-ligand binding was performed as described by Berger et al. (17) with a minor modification. Quantification of autoradiographs was done essentially as described for in situ hybridization analysis.
35. S. Fahn, R. Burke, Y. Stern, Prog. Brain Res. 84, 389 (1990).
36. L. K. Nisenbaum, S. T. Kitai, C. R. Gerfen, Neuroscience 63, 435 (1994).
37. J. Q. Wang and J. F. McGinty, Brain Res. 748, 62 (1997).
38. C. Le Moine and B. Bloch, J. Comp. Neurol. 355, 418 (1995).
39. D. J. Surmeier, A. Reiner, M. S. Levine, M. A. Ariano, Trends Neurosci. 16, 299 (1993)
40. O. Aizman et al., Nature Neurosci. 3, 226 (2000).
41. 3H]-ACh. This work was supported in part by research grants from the Ministry of Education, Science and Culture of Japan and the International Resource Program of the National Cancer Institute.